Hinge Health reported revenue of $212.82M and net income of $43.69M for the quarter ended Jun 2026, up 53.0% year over year. This income statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||
| Revenue | 89.83M | 100.61M | 117.26M | 123.83M | 139.10M | 154.21M | 170.73M | 182.31M | 212.82M |
| Cost of RevenueCost of Rev | 23.21M | 21.36M | 21.17M | 23.59M | 41.34M | 28.01M | 26.70M | 28.07M | 28.87M |
| Gross Profit | 66.62M | 79.26M | 96.09M | 100.23M | 97.76M | 126.20M | 144.03M | 154.23M | 183.95M |
| Operating items | |||||||||
| Research & DevelopmentR&D | 44.89M | 44.57M | 35.45M | 46.72M | 279.96M | 63.52M | 32.76M | 68.80M | 81.41M |
| Selling, General & AdministrativeSG&A | 14.35M | 14.75M | 17.36M | 16.88M | 251.24M | 36.85M | 24.53M | 23.02M | 28.04M |
| Other Operating ExpensesOther Opex | 24.92M | 23.79M | 22.37M | 23.50M | 147.23M | 31.92M | 59.49M | 30.34M | 34.06M |
| Operating ExpensesOpex | 84.17M | 83.10M | 75.18M | 87.10M | 678.43M | 132.29M | 116.77M | 122.16M | 143.51M |
| Operating IncomeOp. Inc | -17.55M | -3.85M | 20.91M | 13.14M | -580.67M | -6.09M | 27.26M | 32.07M | 40.44M |
| EBIT | -17.55M | -3.85M | 20.91M | 13.14M | -580.67M | -6.09M | 27.26M | 32.07M | 40.44M |
| Non-operating items | |||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.01M | -0.06M | -0.04M | -0.33M | -0.02M | ||||
| Non Operating IncomeNon Op. Inc. | 4.99M | 5.29M | 5.25M | 5.00M | 4.69M | 4.46M | 4.96M | 3.87M | 3.99M |
| Net income details | |||||||||
| EBT | -12.56M | 1.45M | 26.16M | 18.14M | -575.98M | -1.64M | 32.22M | 35.94M | 44.43M |
| Tax ProvisionsTaxes | 0.40M | 1.11M | -0.95M | 1.00M | -0.33M | 0.21M | 0.10M | 0.81M | 0.74M |
| Profit After TaxPAT | -12.93M | 0.34M | 27.12M | 17.14M | -575.70M | -1.84M | 32.01M | 35.13M | 43.69M |
| Income from Continuing OperationsIncome (Continuing) | -12.96M | 0.34M | 27.12M | 17.14M | -575.65M | -1.84M | 32.12M | 35.13M | 43.69M |
| Consolidated Net IncomeConsol Net Inc. | -12.96M | 0.34M | 27.12M | 17.14M | -575.65M | -1.84M | 32.12M | 35.13M | 43.69M |
| Income towards Parent CompanyParent Net Inc | -12.96M | 0.34M | 27.12M | 17.14M | -575.65M | -1.84M | 32.12M | 35.13M | 43.69M |
| Preferred Dividend PaymentsPref Dividends | 0.27M | 1.12M | 0.59M | ||||||
| Net Income towards Common StockholdersNet Income | -12.93M | 0.07M | 27.12M | 121.31M | -575.65M | -1.84M | 32.09M | 34.01M | 43.10M |
| Additional items | |||||||||
| EPS (Basic) | -0.96 | 0.01 | 2.00 | 7.91 | -13.10 | -0.02 | 0.59 | 0.43 | 0.55 |
| EPS (Diluted) | -0.96 | 0.00 | 2.00 | 1.31 | -13.10 | -0.02 | 0.59 | 0.41 | 0.52 |
| Shares Outstanding | 13.53M | 13.62M | 13.56M | 15.33M | 43.93M | 78.86M | 54.58M | 78.62M | 78.97M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 13.53M | 16.58M | 13.56M | 92.75M | 43.93M | 78.86M | 54.58M | 82.39M | 83.42M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 80.71M | 80.71M | 80.71M | 80.71M | 80.71M | 78.72M | 79.17M | 77.30M | 80.20M |
| EBITDA | -17.55M | -3.85M | 20.91M | 13.14M | -580.67M | -6.09M | 27.26M | 32.07M | 40.44M |
| Tax Rate | -3.18% | 76.48% | -3.63% | 5.50% | 0.06% | -12.58% | 0.30% | 2.26% | 1.67% |